10-Q Filing

INSIGHT MOLECULAR DIAGNOSTICS INC. CIK: 1642380 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001493152-23-016796`
Period End Date	20230331
Filing Date	20230515
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 70 Cash Flow Statement 62 Stockholders Equity 18 Comprehensive Income 6

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.99M	USD	Point-in-time
Accounts receivable, net of allowance of $172 and $154, respectively	`AccountsReceivableNetCurrent`	$2.01M	USD	Point-in-time
Accounts receivable, net of allowance of $172 and $154, respectively	`AccountsReceivableNetCurrent`	$1.90M	USD	Point-in-time
Marketable equity securities	`EquitySecuritiesFvNi`	$433.00K	USD	Point-in-time
Marketable equity securities	`EquitySecuritiesFvNi`	$553.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$970.00K	USD	Point-in-time
Accounts receivable, allowance for credit loss	`AllowanceForDoubtfulAccountsReceivable`	$154.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$977.00K	USD	Point-in-time
Accounts receivable, allowance for credit loss	`AllowanceForDoubtfulAccountsReceivable`	$172.00K	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$421.00K	USD	Point-in-time
Current assets of discontinuing operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$2.12M	USD	Point-in-time
Current assets of discontinuing operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.65M	USD	Point-in-time
Right-of-use and financing lease assets, net	`FinanceLeaseRightOfUseAsset`	$2.09M	USD	Point-in-time
Right-of-use and financing lease assets, net	`FinanceLeaseRightOfUseAsset`	$2.02M	USD	Point-in-time
Preferred stock no par value	`PreferredStockNoParValue`	-	USD	Point-in-time
Machinery and equipment, net, and construction in progress	`MachineryAndEquipmentNetAndConstructionInProgress`	$8.76M	USD	Point-in-time
Preferred stock no par value	`PreferredStockNoParValue`	-	USD	Point-in-time
Machinery and equipment, net, and construction in progress	`MachineryAndEquipmentNetAndConstructionInProgress`	$6.40M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$61.63M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$56.66M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.70M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.70M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$371.00K	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$367.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, no par value	`CommonStockNoParValue`	-	USD	Point-in-time
TOTAL ASSETS	`Assets`	$82.80M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$100.09M	USD	Point-in-time
Common stock, no par value	`CommonStockNoParValue`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	118.64M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	119.28M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	118.64M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.40M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	119.28M	shares	Point-in-time
Accrued compensation	`AccruedLiabilitiesCurrent`	$2.23M	USD	Point-in-time
Accrued compensation	`AccruedLiabilitiesCurrent`	$1.77M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.37M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.84M	USD	Point-in-time
Accrued severance from acquisition	`AccruedSeveranceFromAcquisitionCurrent`	$2.31M	USD	Point-in-time
Accrued severance from acquisition	`AccruedSeveranceFromAcquisitionCurrent`	$2.31M	USD	Point-in-time
Accrued liabilities from acquisition	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$109.00K	USD	Point-in-time
Accrued liabilities from acquisition	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$109.00K	USD	Point-in-time
Right-of-use and financing lease liabilities, current	`OperatingLeaseAndFinancingLeaseLiabilitiesCurrent`	$775.00K	USD	Point-in-time
Right-of-use and financing lease liabilities, current	`OperatingLeaseAndFinancingLeaseLiabilitiesCurrent`	$815.00K	USD	Point-in-time
Current liabilities of discontinuing operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$236.00K	USD	Point-in-time
Current liabilities of discontinuing operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$2.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.11M	USD	Point-in-time
Right-of-use and financing lease liabilities, noncurrent	`OperatingLeaseLiabilitiesAndFinancingLeaseLiabilitiesNonCurrent`	$2.73M	USD	Point-in-time
Right-of-use and financing lease liabilities, noncurrent	`OperatingLeaseLiabilitiesAndFinancingLeaseLiabilitiesNonCurrent`	$2.55M	USD	Point-in-time
Contingent consideration liabilities	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$27.36M	USD	Point-in-time
Contingent consideration liabilities	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$45.66M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$60.50M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$39.34M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, no par value; stated value $1,000 per share; 6 shares issued and outstanding at March 31, 2023 and December 31, 2022; aggregate liquidation preference of $6,182 and $6,091 as of March 31, 2023 and December 31, 2022, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$5.53M	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, no par value; stated value $1,000 per share; 6 shares issued and outstanding at March 31, 2023 and December 31, 2022; aggregate liquidation preference of $6,182 and $6,091 as of March 31, 2023 and December 31, 2022, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$5.30M	USD	Point-in-time
Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value, 230,000 shares authorized; 119,279 and 118,644 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$294.93M	USD	Point-in-time
Common stock, no par value, 230,000 shares authorized; 119,279 and 118,644 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$295.53M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$43.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$39.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-257.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-260.68M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$65.22M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$56.97M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$37.93M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$34.29M	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$82.80M	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$100.09M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$297.00K	USD	1 Quarter
Net revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$380.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$265.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$105.00K	USD	1 Quarter
Cost of revenues amortization of acquired intangibles	`CostOfRevenuesAmortizationOfAcquiredIntangibles`	$28.00K	USD	1 Quarter
Cost of revenues amortization of acquired intangibles	`CostOfRevenuesAmortizationOfAcquiredIntangibles`	$22.00K	USD	1 Quarter
Gross margin	`GrossProfit`	$247.00K	USD	1 Quarter
Gross margin	`GrossProfit`	$10.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.13M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$695.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$266.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.65M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.41M	USD	1 Quarter
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-18.31M	USD	1 Quarter
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-4.66M	USD	1 Quarter
Impairment loss from intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	1 Quarter
Impairment loss from intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	$4.95M	USD	1 Quarter
Loss on disposal and held for sale assets	`GainLossOnSaleOfOtherAssets`	-	USD	1 Quarter
Loss on disposal and held for sale assets	`GainLossOnSaleOfOtherAssets`	$-1.28M	USD	1 Quarter
Total operating (income) expenses	`OperatingExpenses`	$-5.84M	USD	1 Quarter
Total operating (income) expenses	`OperatingExpenses`	$3.26M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$5.80M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-3.02M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-30.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-10.00K	USD	1 Quarter
Unrealized gain (loss) on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-330.00K	USD	1 Quarter
Unrealized gain (loss) on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$121.00K	USD	1 Quarter
Other income (expenses), net	`OtherNonoperatingIncomeExpense`	$-36.00K	USD	1 Quarter
Other income (expenses), net	`OtherNonoperatingIncomeExpense`	$-2.00K	USD	1 Quarter
Total other income (expenses), net	`NonoperatingIncomeExpense`	$109.00K	USD	1 Quarter
Total other income (expenses), net	`NonoperatingIncomeExpense`	$-396.00K	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.96M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.41M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.96M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-3.41M	USD	1 Quarter
Loss from discontinuing operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-6.88M	USD	1 Quarter
Loss from discontinuing operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-2.93M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$3.03M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-10.29M	USD	1 Quarter
NET INCOME (LOSS) FROM CONTINUING OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC	`NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic`	$-3.41M	USD	1 Quarter
NET INCOME (LOSS) FROM CONTINUING OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC	`NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic`	$4.90M	USD	1 Quarter
NET LOSS FROM DISCONTINUED OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC	`NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic`	$-6.88M	USD	1 Quarter
NET LOSS FROM DISCONTINUED OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC	`NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic`	$-2.50M	USD	1 Quarter
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.29M	USD	1 Quarter
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC	`NetIncomeLossAvailableToCommonStockholdersBasic`	$2.40M	USD	1 Quarter
NET INCOME (LOSS) FROM CONTINUING OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: DILUTED	`NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted`	$-3.41M	USD	1 Quarter
NET INCOME (LOSS) FROM CONTINUING OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: DILUTED	`NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted`	$4.90M	USD	1 Quarter
NET LOSS FROM DISCONTINUED OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: DILUTED	`NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted`	$-6.88M	USD	1 Quarter
NET LOSS FROM DISCONTINUED OPERATIONS ATTRIBUTABLE TO COMMON STOCKHOLDERS: DILUTED	`NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted`	$-2.50M	USD	1 Quarter
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS: DILUTED	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$2.40M	USD	1 Quarter
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS: DILUTED	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-10.29M	USD	1 Quarter
Net income (loss) from continuing operations attributable to common stockholders per share - basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.04	USD	1 Quarter
Net income (loss) from continuing operations attributable to common stockholders per share - basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.04	USD	1 Quarter
Net loss from discontinued operations attributable to common stockholders per share - basic	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.02	USD	1 Quarter
Net loss from discontinued operations attributable to common stockholders per share - basic	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.07	USD	1 Quarter
Net income (loss) attributable to common stockholders per share - basic	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Net income (loss) attributable to common stockholders per share - basic	`EarningsPerShareBasic`	$-0.11	USD	1 Quarter
Net income (loss) from continuing operations attributable to common stockholders per share - diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.04	USD	1 Quarter
Net income (loss) from continuing operations attributable to common stockholders per share - diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.04	USD	1 Quarter
Net loss from discontinued operations attributable to common stockholders per share - diluted	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.02	USD	1 Quarter
Net loss from discontinued operations attributable to common stockholders per share - diluted	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.07	USD	1 Quarter
Net income (loss) attributable to common stockholders per share - diluted	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Net income (loss) attributable to common stockholders per share - diluted	`EarningsPerShareDiluted`	$-0.11	USD	1 Quarter
Weighted average shares outstanding: basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.24M	shares	1 Quarter
Weighted average shares outstanding: basic	`WeightedAverageNumberOfSharesOutstandingBasic`	119.15M	shares	1 Quarter
Weighted average shares outstanding: diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	92.24M	shares	1 Quarter
Weighted average shares outstanding: diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.25M	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$3.03M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-10.29M	USD	1 Quarter
Depreciation expense	`Depreciation`	$450.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$287.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$928.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$22.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$834.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.01M	USD	1 Quarter
Unrealized (gain) loss on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-330.00K	USD	1 Quarter
Unrealized (gain) loss on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$121.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$7.00K	USD	1 Quarter
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-18.31M	USD	1 Quarter
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-4.66M	USD	1 Quarter
Impairment loss from intangible assets	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	-	USD	1 Quarter
Impairment loss from intangible assets	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$4.95M	USD	1 Quarter
Loss on disposal of discontinued operations	`LossOnDisposalOfDiscontinuedOperations`	-	USD	1 Quarter
Loss on disposal of discontinued operations	`LossOnDisposalOfDiscontinuedOperations`	$-149.00K	USD	1 Quarter
Loss on disposal and held for sale assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on disposal and held for sale assets	`GainLossOnDispositionOfAssets1`	$-1.28M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-111.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$685.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$351.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-198.00K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-21.00K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.66M	USD	1 Quarter
Accrued severance and liabilities from Chronix Biomedical acquisition	`AccruedSeveranceAndLiabilitiesFromChronixBiomedicalAcquisition`	$800.00K	USD	1 Quarter
Accrued severance and liabilities from Chronix Biomedical acquisition	`AccruedSeveranceAndLiabilitiesFromChronixBiomedicalAcquisition`	-	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-35.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-33.00K	USD	1 Quarter
Assets held for sale	`IncreaseDecreaseInAssetsHeldForSale`	-	USD	1 Quarter
Assets held for sale	`IncreaseDecreaseInAssetsHeldForSale`	$-421.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.67M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.28M	USD	1 Quarter
Construction in progress and purchases of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Construction in progress and purchases of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.56M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.56M	USD	1 Quarter
Proceeds from sale of common shares under at-the-market transactions	`ProceedsFromSaleOfCommonSharesUnderAtthemarketTransactions`	-	USD	1 Quarter
Proceeds from sale of common shares under at-the-market transactions	`ProceedsFromSaleOfCommonSharesUnderAtthemarketTransactions`	$31.00K	USD	1 Quarter
Financing costs for at-the-market sales	`PaymentForFinancingCostsForAtthemarketSales`	-	USD	1 Quarter
Financing costs for at-the-market sales	`PaymentForFinancingCostsForAtthemarketSales`	$1.00K	USD	1 Quarter
Repayment of loan payable	`RepaymentsOfDebt`	-	USD	1 Quarter
Repayment of loan payable	`RepaymentsOfDebt`	$375.00K	USD	1 Quarter
Repayment of financing lease obligations	`RepaymentOfFinancingLeaseObligations`	$10.00K	USD	1 Quarter
Repayment of financing lease obligations	`RepaymentOfFinancingLeaseObligations`	$28.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-355.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-28.00K	USD	1 Quarter
NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-15.21M	USD	1 Quarter
NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-9.70M	USD	1 Quarter
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.50M	USD	Point-in-time
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.20M	USD	Point-in-time
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.30M	USD	Point-in-time
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$22.09M	USD	Point-in-time
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.50M	USD	Point-in-time
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.20M	USD	Point-in-time
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.30M	USD	Point-in-time
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$22.09M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$13.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Construction in progress, machinery and equipment purchases included in accounts payable, accrued liabilities and landlord liability	`ConstructionInProgressMachineryAndEquipmentPurchasesIncludedInAccountsPayableAccruedliabilitiesAndLandlordLiability`	$27.00K	USD	1 Quarter
Construction in progress, machinery and equipment purchases included in accounts payable, accrued liabilities and landlord liability	`ConstructionInProgressMachineryAndEquipmentPurchasesIncludedInAccountsPayableAccruedliabilitiesAndLandlordLiability`	$993.00K	USD	1 Quarter

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$65.22M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$56.97M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$37.93M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$34.29M	USD	Point-in-time
Net Loss	`NetIncomeLoss`	$3.03M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-10.29M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$2.01M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$834.00K	USD	1 Quarter
Shares issued upon vesting of RSUs	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	1 Quarter
Accretion of Series A convertible preferred stock to redemption value	`StockIssuedDuringPeriodValueAccretionOfSeriesConvertiblePreferredStockToRedemptionValue`	$-230.00K	USD	1 Quarter
Sale of common shares, including at-the-market transactions	`StockIssuedDuringPeriodValueSaleOfCommonSharesIncludingAtthemarketTransactions`	$31.00K	USD	1 Quarter
Financing costs paid to issue common shares, including at-the-market transactions	`StockIssuedDuringPeriodValueOther`	$-1.00K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$65.22M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$56.97M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$37.93M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$34.29M	USD	Point-in-time

Comprehensive Income 6 line items

Line Item	Tag	Value	Unit	Period
NET INCOME (LOSS)	`NetIncomeLoss`	$3.03M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-10.29M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$3.04M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-10.29M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.